- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Idarubicin Hydrochloride
Total 7542 results
-
Technische Universität DresdenUnknownLeukemia, Promyelocytic, AcuteGermany
-
Peking University Third HospitalNot yet recruitingNon-Small Cell Lung Cancer
-
Rush University Medical CenterNational Cancer Institute (NCI)Withdrawn
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedChronic Myeloproliferative DisordersUnited States, United Kingdom, France
-
University Hospital, BonnUnknown
-
WPD Pharmaceuticals Sp. z o.o.Worldwide Clinical TrialsNot yet recruiting
-
PhytoHealth CorporationCompleted
-
Zhejiang UniversityHuashan Hospital; West China Hospital; The First Affiliated Hospital of Zhengzhou... and other collaboratorsTerminatedHepatocellular CarcinomaChina
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Cancer | Primary Peritoneal Cavity CancerUnited States
-
National Institute of Allergy and Infectious Diseases...International Tuberculosis Research CenterWithdrawnRefractory Pulmonary TuberculosisKorea, Republic of
-
Mundipharma K.K.CompletedRecurrent or Refractory T/NK-cell MalignanciesJapan
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
BioCryst PharmaceuticalsCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity CancerUnited States
-
Peking University People's HospitalXijing Hospital; Peking Union Medical College Hospital; Chinese PLA General Hospital and other collaboratorsWithdrawnToxicity | Overall Survival | Progression-free SurvivalChina
-
Yansong LinActive, not recruitingDTC - Differentiated Thyroid CancerChina
-
University of Maryland, BaltimoreSuspendedAortic Aneurysm, ThoracicUnited States
-
Yizhuo ZhangUnknown
-
Mundipharma K.K.CompletedRecurrent or Refractory PTCLJapan
-
GlaxoSmithKlineCompletedAllergic Rhinitis | Seasonal Allergic RhinitisJapan
-
Jiangsu Simcere Pharmaceutical Co., Ltd.UnknownNon-small Cell Lung CancerChina
-
AVEO Pharmaceuticals, Inc.CompletedHepatic ImpairmentUnited States
-
Institute of Cancer Research, United KingdomNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited Kingdom
-
BioCryst PharmaceuticalsCompleted
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
SK Chemicals Co., Ltd.Toray Industries, IncCompletedChronic Renal FailureKorea, Republic of
-
IntraBiotics PharmaceuticalsTerminated
-
Cancer Institute and Hospital, Chinese Academy...RecruitingAnlotinib | Sarcoma,Soft Tissue | Trunk | Extremity | Intensity-modulated Radiotherapy | Major Wound ComplicationsChina
-
WPD Pharmaceuticals Sp. z o.o.National Center for Research and Development, Poland; Worldwide Clinical TrialsRecruitingRecurrent Glioblastoma MultiformePoland
-
The First Hospital of Jilin UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownNon-Small Cell Lung CancerChina
-
LanZhou UniversityGeneral Hospital of Ningxia Medical UniversityUnknown
-
Forest LaboratoriesCompleted
-
Forest LaboratoriesCompleted
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Unknown
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Institut de Recherches Internationales ServierCelgene CorporationActive, not recruitingUntreated AML | Newly Diagnosed Acute Myeloid Leukemia (AML) | AML Arising From Myelodysplastic Syndrome (MDS) | AML Arising From Antecedent Hematologic Disorder (AHD) | AML Arising After Exposure to Genotoxic InjuryUnited States, Germany, Netherlands
-
Shanghai Jiao Tong University School of MedicineThe First Affiliated Hospital with Nanjing Medical University; The First Affiliated... and other collaboratorsUnknownAcute Promyelocytic LeukemiaChina
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National... and other collaboratorsActive, not recruitingSafety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia (IDAML)Leukemia, Myeloid, AcuteKorea, Republic of
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedLymphomaUnited States, Brazil, Chile
-
Peking Union Medical College HospitalRecruitingPheochromocytoma | ParagangliomaChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdNot yet recruitingNovel COVID-19-Infected PneumoniaChina
-
Peking Union Medical College HospitalRecruitingParaganglioma, Extra-Adrenal | Malignant Adrenal Gland Pheochromocytoma | Malignant Paraganglioma | Pheochromocytoma, Metastatic | Paraganglioma, MalignantChina
-
Tianjin Medical University Cancer Institute and...Enrolling by invitationRecurrent/Refractory Classical Hodgkin's LymphomaChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompletedMyelofibrosisChina
-
Suzhou Zelgen Biopharmaceuticals Co.,LtdCompleted
-
Shanghai Zhongshan HospitalWithdrawn
-
Eiger Group International, Inc.Unknown
-
Forest LaboratoriesCompleted
-
Seoul National University HospitalGuerbetRecruitingHepatocellular Carcinoma | Liver CancerKorea, Republic of